Richard H. P. Porter

机构：Texas Tech University, UniQure (Netherlands)

发表论文 200 篇 · 总被引 8520 次 · h-index 49

代表论文

• Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity (2005 · Journal of Pharmacology and Experimental Therapeutics · 被引 315)
• Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease (2011 · Biochemical Pharmacology · 被引 225)
• CTEP: A Novel, Potent, Long-Acting, and Orally Bioavailable Metabotropic Glutamate Receptor 5 Inhibitor (2011 · Journal of Pharmacology and Experimental Therapeutics · 被引 123)
• RG3487, a Novel Nicotinic α7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents (2010 · Journal of Pharmacology and Experimental Therapeutics · 被引 116)
• The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison (2005 · Psychopharmacology · 被引 111)
• Pharmacology of Basimglurant (RO4917523, RG7090), a Unique Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator in Clinical Development for Depression (2015 · Journal of Pharmacology and Experimental Therapeutics · 被引 106)